Yan Wang

Jining Medical University

H指数:14

被引数:878

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical characteristics of endometrial cancers with microsatellite instability-high and BRCA1/2 mutations

微卫星不稳定性高和BRCA1/2突变子宫内膜癌的临床特征

Frontiers in Oncology

IF3.3

2025-12-040

OAAI

Integration of genomic and clinical variables improves the prediction of myelodysplastic syndromes to acute myeloid leukaemia transformation and prognosis

整合基因组学和临床变量可提高骨髓增生异常综合征向急性髓系白血病转化的预测及预后评估

BRITISH JOURNAL OF HAEMATOLOGY

IF3.8

2025-12-010

Penichrysosterol, a novel dual inhibitor of ferroptosis and neuroinflammation from the deep-sea fungus Penicillium chrysogenum

Penichrysosterol，一种来自深海真菌Penicillium chrysogenum的新型铁死亡和神经炎症双重抑制剂

Bioorganic Chemistry

IF4.7

2025-11-060

PRE

Recent Advances of Secondary Metabolites From Marine-Derived Aspergillus versicolor: Chemical Diversity and Bioactivities (2015-2024)

CHEMISTRY & BIODIVERSITY

IF2.5

2025-10-010

PRE

AMCF-RDP: a self-attention-based multi-source and cascade framework for the identification of drug–protein relationships

AMCF-RDP：一种基于自注意力机制的多源级联框架，用于识别药物-蛋白质关系

Molecular Diversity

IF3.8

2025-08-270

PRE

The Cytotoxic Activity of Secondary Metabolites from Marine-Derived Penicillium spp.: A Review (2018-2024)

海洋来源青霉属次级代谢产物的细胞毒性活性：2018-2024年综述

MARINE DRUGS

IF5.4

2025-04-300

The single-cell transcriptional landscape of lung cells from PCV2d-infected mice

FRONTIERS IN MICROBIOLOGY

IF4.5

2025-03-240

OAAI

SH3GL1-activated FTH1 inhibits ferroptosis and confers doxorubicin resistance in diffuse large B-cell lymphoma

SH3GL1激活的FTH1抑制铁死亡并赋予弥漫性大B细胞淋巴瘤对多柔比星的耐药性

CLINICAL AND TRANSLATIONAL MEDICINE

IF6.8

2025-03-040

OAAI

Developing and validating a drug recommendation system based on tumor microenvironment and drug fingerprint

FRONTIERS IN ARTIFICIAL INTELLIGENCE

IF4.7

2025-01-080

OAAI

Small Intestinal Slow Wave Dysrhythmia and Blunted Postprandial Responses in Diabetic Rats

NEUROGASTROENTEROLOGY AND MOTILITY

IF2.9

2025-01-060

Potential shared gene signatures and molecular mechanisms between recurrent pregnancy loss and ovarian cancer

FRONTIERS IN ONCOLOGY

IF3.3

2024-11-140

OAAI

Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients (vol 103, pg 2323, 2024)

ANNALS OF HEMATOLOGY

IF2.4

2024-06-240

Identification of EGR4 as a prospective target for inhibiting tumor cell proliferation and a novel biomarker in colorectal cancer

CANCER GENE THERAPY

IF5

2024-03-080

PRE

Loeys-Dietz syndrome with concomitant aplastic anemia

ANNALS OF HEMATOLOGY

IF2.4

2024-02-020

PRE

MiR-548t-5p regulates pancreatic ductal adenocarcinoma metastasis through an IL-33-dependent crosstalk between cancer cells and M2 macrophages

CELL CYCLE

IF3.4

2024-01-2412

PRE

Esophagogastric Junction Outflow Obstruction Is Likely to Be a Local Manifestation of Other Primary Diseases: Analysis of Single-Center 4-Year Follow-Up Data

DIAGNOSTICS

IF3.3

2023-07-101

OAAI

Randomized Controlled Trial of Anti-ref lux Mucosectomy Versus Radiofrequency Energy Delivery for Proton Pump Inhibitor-refractory Gastroesophageal Reflux Disease

neurogastroenterology and motility

IF3.3

2023-06-198

OAAI

Machine learning-based neddylation landscape indicates different prognosis and immune microenvironment in endometrial cancer

FRONTIERS IN ONCOLOGY

IF3.3

2023-02-2210

OAAI

Clinical significance and related factors of rectal hyposensitivity in patients with functional defecation disorder

FRONTIERS IN MEDICINE

IF3

2023-02-210

OAAI

Diagnostic Methods for Evaluation of Gastric Motility-A Mini Review

DIAGNOSTICS

IF3.3

2023-02-207

Yan Wang

个人简介

教育背景

工作经历

荣誉奖项

研究方向